102 related articles for article (PubMed ID: 21033079)
1. [Non-alcoholic fatty liver disease as an atherosclerosis risk factor].
Roĭtberg GE; Sharkhun OO; Ushakova TI
Eksp Klin Gastroenterol; 2010; (7):20-4. PubMed ID: 21033079
[TBL] [Abstract][Full Text] [Related]
2. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Zenari L; Cigolini M; Falezza G; Arcaro G
Diabetes Care; 2006 Jun; 29(6):1325-30. PubMed ID: 16732016
[TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.
Loria P; Lonardo A; Bellentani S; Day CP; Marchesini G; Carulli N
Nutr Metab Cardiovasc Dis; 2007 Nov; 17(9):684-98. PubMed ID: 17560098
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens.
Targher G
Diabet Med; 2007 Jan; 24(1):1-6. PubMed ID: 17227317
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease and vascular risk.
Bhatia LS; Curzen NP; Byrne CD
Curr Opin Cardiol; 2012 Jul; 27(4):420-8. PubMed ID: 22596186
[TBL] [Abstract][Full Text] [Related]
6. [Non-alcoholic fatty liver disease: a new challenge for cardiologists].
Tarquini R; Lazzeri C; Boddi M; Marra F; Abbate R; Gensini GF
G Ital Cardiol (Rome); 2010 Sep; 11(9):660-9. PubMed ID: 21348181
[TBL] [Abstract][Full Text] [Related]
7. [Hypolipidemic therapy in patients with non-alcoholic fatty liver disease].
Zvenigorodskaia LA; Samsonova NG; Mel'nikova NV; Cherkashova EA
Eksp Klin Gastroenterol; 2010; (7):25-33. PubMed ID: 21033080
[TBL] [Abstract][Full Text] [Related]
8. Increased arterial stiffness and impaired endothelial function in nonalcoholic Fatty liver disease: a pilot study.
Vlachopoulos C; Manesis E; Baou K; Papatheodoridis G; Koskinas J; Tiniakos D; Aznaouridis K; Archimandritis A; Stefanadis C
Am J Hypertens; 2010 Nov; 23(11):1183-9. PubMed ID: 20634799
[TBL] [Abstract][Full Text] [Related]
9. Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass.
Picardi A; Vespasiani-Gentilucci U
Am J Gastroenterol; 2008 Dec; 103(12):3036-8. PubMed ID: 18853984
[TBL] [Abstract][Full Text] [Related]
10. [Non-alcoholic fatty liver disease--new view].
Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
[TBL] [Abstract][Full Text] [Related]
11. The role of non-alcoholic fatty liver disease in cardiovascular disease.
Perseghin G
Dig Dis; 2010; 28(1):210-3. PubMed ID: 20460913
[TBL] [Abstract][Full Text] [Related]
12. [Non-alcoholic fatty liver].
Tagle Arrospide M
Rev Gastroenterol Peru; 2003; 23(1):49-57. PubMed ID: 12768215
[TBL] [Abstract][Full Text] [Related]
13. [Non-alcoholic fatty liver disease in dyslipidemia and insulin resistance: similarities and differences; differential approach to therapy].
Lazebnik LB; Zvenigorodskaia LA; Egorova EG; Mel'nikova NV; Khomeriki SG
Eksp Klin Gastroenterol; 2009; (8):4-11. PubMed ID: 20469672
[TBL] [Abstract][Full Text] [Related]
14. Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C.
Targher G; Bertolini L; Padovani R; Rodella S; Arcaro G; Day C
J Hepatol; 2007 Jun; 46(6):1126-32. PubMed ID: 17335930
[TBL] [Abstract][Full Text] [Related]
15. Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease.
Demircioğlu F; Koçyiğit A; Arslan N; Cakmakçi H; Hizli S; Sedat AT
J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):68-75. PubMed ID: 18607271
[TBL] [Abstract][Full Text] [Related]
16. Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis.
Loria P; Lonardo A; Targher G
Clin Sci (Lond); 2008 Jul; 115(1):1-12. PubMed ID: 19016656
[TBL] [Abstract][Full Text] [Related]
17. Significant correlations between severe fatty liver and risk factors for metabolic syndrome.
Hsiao PJ; Kuo KK; Shin SJ; Yang YH; Lin WY; Yang JF; Chiu CC; Chuang WL; Tsai TR; Yu ML
J Gastroenterol Hepatol; 2007 Dec; 22(12):2118-23. PubMed ID: 18031368
[TBL] [Abstract][Full Text] [Related]
18. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
[TBL] [Abstract][Full Text] [Related]
19. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease.
Angulo P; Alba LM; Petrovic LM; Adams LA; Lindor KD; Jensen MD
J Hepatol; 2004 Dec; 41(6):943-9. PubMed ID: 15582127
[TBL] [Abstract][Full Text] [Related]
20. [Taurine in the treatment of non-alcoholic fatty liver disease].
Zvenigorodskaia LA; Ovsiannikova ON; Noskova KK; Nilova TV; Elizarova EP
Eksp Klin Gastroenterol; 2010; (7):43-50. PubMed ID: 21033082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
